Early Total White Blood Cell Recovery Is A Predictor Of Low Number Of Apheresis And Good Cd34+ Cell Yield

dc.creatorMarques J.F.C.
dc.creatorVigorito A.C.
dc.creatorAranha F.J.P.
dc.creatorLorand-Metze I.
dc.creatorMiranda E.C.M.
dc.creatorLima Filho E.C.
dc.creatorValbonesi M.
dc.creatorSantini G.
dc.creatorDe Souza C.A.
dc.date2000
dc.date2015-06-30T19:50:55Z
dc.date2015-11-26T14:47:12Z
dc.date2015-06-30T19:50:55Z
dc.date2015-11-26T14:47:12Z
dc.date.accessioned2018-03-28T21:57:25Z
dc.date.available2018-03-28T21:57:25Z
dc.identifier
dc.identifierTransfusion And Apheresis Science. , v. 23, n. 2, p. 91 - 100, 2000.
dc.identifier14730502
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-0346384850&partnerID=40&md5=9eb3c9bd5b7d19bd01d0bbe465cbf579
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/107261
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/107261
dc.identifier2-s2.0-0346384850
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1253165
dc.descriptionObjective. We analysed peripheral blood progenitor cell (PBPC) mobilisation and collection in order to assess the main factors related to CD34+ cell yields in patients affected by haematological malignancies. Patients and Methods. The features of CD34+ cell mobilisation of patients with haematological malignancies that underwent autologous bone marrow transplantation were examined. Mobilisation chemotherapy consisted mainly of cyclophosphamide (CY) 4 or 7 g/m2 followed by growth factors. Leukapheresis was started when the WBC counts reached 1.0×109/l with the aim to collect at least 5×106 CD34+ cells/kg body weight. The aphereses were performed on continuous-flow blood cell separators. The analysed variables were: age, diagnosis, CT mobilisation regimen, type of growth factor, number of previous CT lines, prior radiotherapy, days for WBC recovery and number of aphereses procedures to achieve the target of CD34+ cells. Results. There were 41 consecutive patients (26 M/15 F): 21 non-Hodgkin's lymphoma (NHL), 15 Hodgkin's disease (HD), two chronic myeloid leukaemia (CML) and three multiple myeloma (MM). Eleven patients could not collect the proposed threshold of CD34+ cells. CY 4 mobilised patients recovered WBC counts in less days (P=0.03). By ANOVA, the days to WBC recovery had a linear function of the predictors "number of aphereses" and "type of mobilisation CT" (coefficients: 0.86 and 0.95, respectively). For the number of aphereses and WBC recovery after CT mobilisation, we obtained a correlation coefficient of 0.36 (P=0.02). Conclusion. This study shows that it is feasible to mobilise and collect PBPC in patients previously treated with CT with or without RT. There was a linear correlation between the days for WBC recovery and the number of aphereses needed to collect the target number of CD34+ cells. The study suggests that early WBC recovery, using mainly CY 4 mobilisation chemotherapy, is an important predictor of a low number of aphereses to achieve a good CD34+ yield. © 2000 Elsevier Science Ltd. All rights reserved.
dc.description23
dc.description2
dc.description91
dc.description100
dc.descriptionKessinger, A., Armitage, J.O., Landmark, J.D., Autologous peripheral haematopoietic stem cell transplantation restores hematopoietic function following ablative therapy (1988) Blood, 71, pp. 723-727
dc.descriptionWilliams, S.F., Bitran, J.D., Richards, J.M., Peripheral blood-derived stem cell collections for use in autologous transplantation after high-dose chemotherapy: An alternative approach (1990) Bone Marrow Transplant, 5, pp. 129-133
dc.descriptionKessinger, A., Armitage, J.O., Smith, D.M., High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma (1989) Blood, 74, pp. 1260-1264
dc.descriptionDreyfus, F., Leblond, V., Belander, C., Peripheral blood stem cell collection and autografting in high risk lymphomas (1992) Bone Marrow Transplant, 10, pp. 409-413
dc.descriptionSantini, G., Congiu, A.M., Nati, S., Mobilisation/ transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement (1996) Leukaemia, 10, pp. S88-91
dc.descriptionGianni, A.M., Siena, S., Bregni, M., High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease - A 6-year update (1993) Ann Oncol, 4, pp. 889-891
dc.descriptionBierman, P.J., Vose, J.M., Armitage, J.O., Autologous transplantation for Hodgkin's disease: Coming of age (1994) Blood, 83, pp. 1161-1164
dc.descriptionFermand, J.-P., Chevret, S., Ravaud, P., High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients (1993) Blood, 82, pp. 2005-2009
dc.descriptionMarit, G., Faberes, C., Pico, J.L., Autologous peripheral-blood progenitor-cell support following high-dose chemotherapy of chemoradiotherapy in patients with high-risk multiple myeloma (1996) J Clin Oncol, 14, pp. 1306-1313
dc.descriptionCarella, A.M., Celesti, L., Lerma, E., Dejana, A., Frassoni, F., Stem cell mobilisation for autografting in chronic myeloid leukaemia (1997) Blood Rev, 11, pp. 154-159
dc.descriptionTo, L.B., Haylock, D.N., Simmons, P.J., Juttner, C.A., The biology and clinical uses of blood stem cells (1997) Blood, 89, pp. 2233-2258
dc.descriptionBensinger, W., Appelbaum, F., Rowley, S., Factors that influence collection and engraftment of autologous peripheral-blood stem cells (1995) J Clin Oncol, 13, pp. 2547-2555
dc.descriptionTricot, G., Jagannath, S., Vesole, D.H., Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients (1995) Blood, 85, pp. 588-596
dc.descriptionKiss, J.E., Rybka, W.B., Winkelstein, A., Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation (1997) Bone Marrow Transplant, 19, pp. 303-310
dc.descriptionTarella, C., Ferrero, D., Bregni, M., Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF (1991) Eur J Cancer, 27, pp. 22-27
dc.descriptionGoldschimidt, H., Hegenbart, U., Haas, R., Hunstein, W., Mobilisation of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma (1996) Bone Marrow Transplant, 17, pp. 691-697
dc.descriptionKetterer, N., Salles, G., Moullet, I., Factors associated with successful mobilisation of peripheral blood progenitor cells in 200 patients with lymphoid malignancies (1998) Br J Haematol, 103, pp. 235-242
dc.descriptionHaas, R., Mohle, R., Fruhauf, S., Patient characteristics associated with successful mobilising and autografting of peripheral blood progenitor cells in malignant lymphoma (1994) Blood, 83, pp. 3787-3794
dc.descriptionGoldschmidt, H., Hegenbart, U., Wallmeier, M., Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma (1997) Br J Haematol, 98, pp. 736-744
dc.descriptionDreger, P., Klöss, M., Petersen, B., Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts (1995) Blood, 86, pp. 3970-3978
dc.descriptionKotasek, D., Shepherd, K.M., Sage, R.E., Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilisation in lymphoma, myeloma and solid tumors (1992) Bone Marrow Transplant, 9, pp. 11-17
dc.descriptionWatts, M.J., Sullivan, A.M., Jamieson, E., Progenitor-cell mobilisation after low-dose cyclophosphamide and granulocyte colony-stimulating factor: An analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma (1997) J Clin Oncol, 15, pp. 535-546
dc.descriptionSchwella, N., Siegert, W., Beyer, J., Autografting with blood progenitor cells: Predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution (1995) Ann Hematol, 71, pp. 227-234
dc.descriptionRemes, K., Mantinlauri, I., Grenman, S., Daily measurements of blood CD34+ cells after stem cell mobilisation predict stem cell yield and posttransplant hematopoietic recovery (1997) J Hematother, 6, pp. 13-19
dc.descriptionSmolowicz, A.G., Villman, K., Tidefelt, U., Large volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation (1997) Transfusion, 37, pp. 188-192
dc.descriptionFord, C.D., Pace, N., Lehman, C., Factors affecting the efficiency of collection of CD34- positive peripheral blood cells by a blood cell separator (1998) Transfusion, 38, pp. 1046-1050
dc.descriptionSantini, G., De Souza, C., Congiu, A.M., High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow (1999) Leuk Lymphoma, 33, pp. 321-330
dc.descriptionVelasquez, W.S., Cabanillas, F., Salvador, P., Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP) (1988) Blood, 71, pp. 117-122
dc.descriptionCarella, A.M., Frassoni, F., ICE, mini-ICE or high-dose hydroxyurea to mobilise Philadelphia [Ph]-negative PBPC in chronic myelogenous leukaemia (1996) Br J Haematol, 95, pp. 213-214
dc.descriptionCaracciolo, D., Gavarotti, P., Aglietta, M., High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis relapsed non-Hodgkin's lymphoma (1993) Bone Marrow Transplant, 12, pp. 621-625
dc.descriptionSutherland, D.R., Keating, A., Nayar, R., Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry (1994) Exp Hematol, 22, pp. 1003-1110
dc.descriptionArmitage, P., Berry, G., (1994) Statistical Methods in Medical Research, 3rd Ed., , Oxford: Oxford University Press
dc.descriptionRao, C.R., (1995) Linear Models: Least Squares and Alternatives, p. 352. , New York: Springer
dc.descriptionD'Arena, G., Musto, P., Di Mauro, L., Predictive parameters for mobilised peripheral blood CD34+ progenitor cell collection in patients with haematological malignancies (1998) Am J Haematol, 58, pp. 255-262
dc.descriptionGandhi, M.K., Jestice, K., Scott, M.A., The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients (1999) Bone Marrow Transplant, 23, pp. 9-13
dc.descriptionValbonesi, M., Hemopoietic stem cells: Technical and methodological considerations (1993) Stem Cells, OCTOBER 11 (3 SUPPL.), pp. 58-63
dc.descriptionTo, L.B., Shepperd, K.M., Haylock, D.N., Single high-doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood (1990) Exp Hematol, 18, pp. 442-447
dc.descriptionRowlings, P.A., Bayly, J.L., Rawling, C.M., Juttner, C.A., Tokljklkl, L.B., A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 or 7 g/m2 in patients with advanced cancer (1992) Aust N Z J Med, 22, pp. 660-664
dc.descriptionDe Luca, E., Sheridan, W.P., Watson, D., Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells (1992) Br J Cancer, 66, pp. 893-899
dc.descriptionRichman, C., Weiner, R., Yankee, R., Increase in circulating stem cell following chemotherapy in man (1976) Blood, 47, pp. 1031-1039
dc.descriptionSiena, S., Bregni, M., Brando, B., Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: Enhancement by intravenous recombinant human granulocyte macrophage colony stimulating factor (1989) Blood, 74, pp. 1905-1914
dc.descriptionHaas, R., Hohaus, S., Egerer, G., Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest (1992) Bone Marrow Transplant, 9, pp. 459-465
dc.descriptionBoiron, J.M., Marit, G., Faberes, C., Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) (1993) Bone Marrow Transplant, 12, pp. 49-55
dc.descriptionPeters, W.P., Rosner, G., Ross, M., Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy (1993) Blood, 7, pp. 1709-1719
dc.descriptionBolwell, B., Goormastic, M., Yanssens, T., Comparison of G-CSF with GM-CSF for mobilising peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant (1994) Bone Marrow Transplant, 14, pp. 913-918
dc.descriptionKrause, D.S., Mechanic, S.A., Snyder, E.L., Mobilisation and collection of peripheral blood progenitor cells (1997) Apheresis: Principles and Practice, pp. 433-451. , McLeod BC, Price TH, editors. Bethesda, MD: AABB Press
dc.languageen
dc.publisher
dc.relationTransfusion and Apheresis Science
dc.rightsfechado
dc.sourceScopus
dc.titleEarly Total White Blood Cell Recovery Is A Predictor Of Low Number Of Apheresis And Good Cd34+ Cell Yield
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución